4808
FDA: Update from the U.S. Food and Drug Administration
Monday, March 3, 2014: 4:45 PM-6:00 PM
Convention Center, Upper Level, Ballroom 6A
1.25 CME/ 1.50 CE
Moderator:
F. Estelle R. Simons , MD FAAAAI
Learning Objectives:
  1. Review recent issues of scientific importance at FDA and their regulatory implications
  2. Identify issues related to the over-the-counter (OTC) marketing of allergy drug products
  3. Recognize issues in the clinical development of drug products for eosinophilic asthma
4:45 PM
Year-in-Review: An Update from the U.S. Food and Drug Administration
Badrul A. Chowdhury, MD PhD FAAAAI
5:00 PM
Over-the-Counter (OTC) Marketing of Allergy Drug Products
Sofia Chaudhry, MD
5:15 PM
Eosinophilic Asthma: Considerations for Drug Product Development
Susan Lee Limb, MD FAAAAI
5:30 PM
Question & Answer
See more of: Q & A Workshop